INSIGHTS ON CLINICAL TRIAL DESIGN
-
How Protocol Design Decisions Shape Recruitment, Data Quality & Study Startup
Protocol design directly affects recruitment, data quality, and startup speed. Clear workflows, streamlined criteria, and early alignment reduce delays, amendments, and improve reliable study execution.
-
Challenges, Opportunities For Recruitment In The Digital Age
Health literacy gaps and online misinformation hinder clinical trial recruitment. Meeting patients where they are — digitally and educationally — can improve engagement and enrollment success.
-
The Psychedelic Setback: What MDMA Rejection Taught Drug Developers
Psychedelic compounds show real promise for PTSD, but proving it requires solving unblinding, bias, and safety gaps in trial design.
-
Beyond Automation: Transforming Clinical Trial Delivery Through Structured Information
Study build delays stem less from slow tasks than from protocol intent being reinterpreted at every handoff. Treating the protocol as structured, reusable information changes where AI and expertise belong.
-
Navigating The Complex World Of First In Human Oncology Trials5/6/2025
First-in-human oncology trials are critical touchpoints in the development of novel cancer therapies, requiring precise scientific execution and a deeply patient-centric approach.
-
The Patient Recruitment Shift: Navigating Disruption, Delivering Precision3/27/2025
Explore the four macro trends reshaping the recruitment space in 2025—each grounded in emerging data, technology, and behavior shifts.
-
Evolving IRT For Today's Trials: Flexibility, Site Experience, And Integrated Workflow5/19/2026
Interactive Response Technology is evolving beyond traditional randomization and trial supply management to help guide protocol workflows in increasingly complex studies.
-
Travel And Payment Services: A Patient's Journey12/5/2025
Streamline patient travel and payments in your clinical trials by implementing centralized, high-quality concierge services that reduce burdens, improve satisfaction, and boost study performance.
-
Practical ICH E6(R3) Oversight For Your Centralized Monitoring Strategy3/17/2026
Bridge the gap between fragmented data and ICH E6(R3) compliance. Learn to use unified data signals to catch consent errors and enrollment delays before they trigger audit findings.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Advancing a novel therapy through clinical development is complicated. Not all therapies make it to the patients that need them.
-
CSSi is a global, full-service company offering customized services to support recruitment and retention programs around the world.
-
CVRM trials must address comorbidities and complex needs. See how real-world data and expertise improve design, speed recruitment, and advance cardiovascular, renal, and metabolic care.
-
Simplify biosafety oversight and accelerate study startup with expert guidance that ensures NIH compliance while protecting researchers, communities, and the environment.
-
Validate endpoint performance and security before deployment with structured UAT that reduces risk, ensures compliance, and enhances user experience through real-world testing.